The effect of intravitreal injections on dry eye, and proposed management strategies

Augustinus Laude,1–3 Jimmy WK Lim,1,2 Vishwanath Srinagesh,4 Louis Tong2,5–7 1National Healthcare Group Eye Institute, Tan Tock Seng Hospital, 2Singapore Eye Research Institute, 3Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; 4Krieger Eye Institu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Laude A, Lim JWK, Srinagesh V, Tong L
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://doaj.org/article/23e486a9f8e542aba69d8c748c58c022
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:23e486a9f8e542aba69d8c748c58c022
record_format dspace
spelling oai:doaj.org-article:23e486a9f8e542aba69d8c748c58c0222021-12-02T07:59:13ZThe effect of intravitreal injections on dry eye, and proposed management strategies1177-5483https://doaj.org/article/23e486a9f8e542aba69d8c748c58c0222017-08-01T00:00:00Zhttps://www.dovepress.com/the-effect-of-intravitreal-injections-on-dry-eye-and-proposed-manageme-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Augustinus Laude,1–3 Jimmy WK Lim,1,2 Vishwanath Srinagesh,4 Louis Tong2,5–7 1National Healthcare Group Eye Institute, Tan Tock Seng Hospital, 2Singapore Eye Research Institute, 3Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; 4Krieger Eye Institute, Baltimore, MD, USA; 5Singapore National Eye Centre, 6Duke NUS Medical School, 7Yong Loo Lin School of Medicine, National University of Singapore, Singapore Abstract: Intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF) agents has become a commonly used treatment method for a number of ophthalmic conditions, including age-related macular degeneration. Although anti-VEGF therapy has shown promising results for many patients, there are several aspects of its application that have not been thoroughly investigated. One of these is the development and/or escalation of concurrent dry eye syndrome. Many patients undergoing treatment are already predisposed to dry eye disease due to their age and overall ocular health. As dry eye can have a substantial impact on quality of life, it has become increasingly apparent that the clinical signs and symptoms should be closely monitored and aggressively managed. This will allow for the optimization of patient comfort and visual potential. Here, we discuss the reasons why dry eye may develop during the course of repeated ocular anti-VEGF therapy, highlighting the key concerns about current practices and proposing possible solutions to improve the outcome for the patients. Keywords: age-related macular degeneration, povidone–iodine, toxicity, ocular health, chronic ophthalmic treatmentLaude ALim JWKSrinagesh VTong LDove Medical PressarticleAge-related macular degeneration (AMD)povidone-iodinetoxicityocular healthchronic ophthalmic treatmentOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 11, Pp 1491-1497 (2017)
institution DOAJ
collection DOAJ
language EN
topic Age-related macular degeneration (AMD)
povidone-iodine
toxicity
ocular health
chronic ophthalmic treatment
Ophthalmology
RE1-994
spellingShingle Age-related macular degeneration (AMD)
povidone-iodine
toxicity
ocular health
chronic ophthalmic treatment
Ophthalmology
RE1-994
Laude A
Lim JWK
Srinagesh V
Tong L
The effect of intravitreal injections on dry eye, and proposed management strategies
description Augustinus Laude,1–3 Jimmy WK Lim,1,2 Vishwanath Srinagesh,4 Louis Tong2,5–7 1National Healthcare Group Eye Institute, Tan Tock Seng Hospital, 2Singapore Eye Research Institute, 3Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; 4Krieger Eye Institute, Baltimore, MD, USA; 5Singapore National Eye Centre, 6Duke NUS Medical School, 7Yong Loo Lin School of Medicine, National University of Singapore, Singapore Abstract: Intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF) agents has become a commonly used treatment method for a number of ophthalmic conditions, including age-related macular degeneration. Although anti-VEGF therapy has shown promising results for many patients, there are several aspects of its application that have not been thoroughly investigated. One of these is the development and/or escalation of concurrent dry eye syndrome. Many patients undergoing treatment are already predisposed to dry eye disease due to their age and overall ocular health. As dry eye can have a substantial impact on quality of life, it has become increasingly apparent that the clinical signs and symptoms should be closely monitored and aggressively managed. This will allow for the optimization of patient comfort and visual potential. Here, we discuss the reasons why dry eye may develop during the course of repeated ocular anti-VEGF therapy, highlighting the key concerns about current practices and proposing possible solutions to improve the outcome for the patients. Keywords: age-related macular degeneration, povidone–iodine, toxicity, ocular health, chronic ophthalmic treatment
format article
author Laude A
Lim JWK
Srinagesh V
Tong L
author_facet Laude A
Lim JWK
Srinagesh V
Tong L
author_sort Laude A
title The effect of intravitreal injections on dry eye, and proposed management strategies
title_short The effect of intravitreal injections on dry eye, and proposed management strategies
title_full The effect of intravitreal injections on dry eye, and proposed management strategies
title_fullStr The effect of intravitreal injections on dry eye, and proposed management strategies
title_full_unstemmed The effect of intravitreal injections on dry eye, and proposed management strategies
title_sort effect of intravitreal injections on dry eye, and proposed management strategies
publisher Dove Medical Press
publishDate 2017
url https://doaj.org/article/23e486a9f8e542aba69d8c748c58c022
work_keys_str_mv AT laudea theeffectofintravitrealinjectionsondryeyeandproposedmanagementstrategies
AT limjwk theeffectofintravitrealinjectionsondryeyeandproposedmanagementstrategies
AT srinageshv theeffectofintravitrealinjectionsondryeyeandproposedmanagementstrategies
AT tongl theeffectofintravitrealinjectionsondryeyeandproposedmanagementstrategies
AT laudea effectofintravitrealinjectionsondryeyeandproposedmanagementstrategies
AT limjwk effectofintravitrealinjectionsondryeyeandproposedmanagementstrategies
AT srinageshv effectofintravitrealinjectionsondryeyeandproposedmanagementstrategies
AT tongl effectofintravitrealinjectionsondryeyeandproposedmanagementstrategies
_version_ 1718398710215344128